We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+28.1%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
10 Year Est. Return
AUM
$544M
AUM Growth
+$63.9M
Cap. Flow
-$11.1M
Cap. Flow %
-2.03%
Top 10 Hldgs %
61.81%
Holding
70
New
10
Increased
18
Reduced
20
Closed
9

Top Buys

Rank Stock Value
1
OPEN icon
Opendoor
OPEN
+$18.9M
2
CBRS
Cerebras Systems
CBRS
+$14.2M
3
SPCX
SpaceX
SPCX
+$6.8M
4
AMZN icon
Amazon
AMZN
+$3.77M
5
TSLA icon
Tesla
TSLA
+$2.39M

Top Sells

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$13.8M
2
SE icon
Sea Limited
SE
+$11.4M
3
ARWR icon
Arrowhead Research
ARWR
+$9.8M
4
ESPR
Esperion Therapeutics
ESPR
+$9.04M
5
SPOT icon
Spotify
SPOT
+$5.72M

Sector Composition

Rank Sector Weight
1 Healthcare 32.64%
2 Technology 26.47%
3 Consumer Discretionary 23.86%
4 Financials 6.2%
5 Communication Services 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1
Tesla
TSLA
$1.38T
$95.9M 17.62%
228,000
+6,000
+3% +$2.39M
SHOP icon
2
Shopify
SHOP
$197B
$42.2M 7.76%
370,000
-37,000
-9% -$4.22M
AMD icon
3
Advanced Micro Devices
AMD
$760B
$36M 6.62%
62,000
AMZN icon
4
Amazon
AMZN
$2.87T
$33.4M 6.13%
140,000
+15,000
+12% +$3.77M
IONS icon
5
Ionis Pharmaceuticals
IONS
$10.1B
$25.4M 4.66%
319,924
+29,900
+10% +$2.25M
SPOT icon
6
Spotify
SPOT
$113B
$25.3M 4.64%
55,000
-12,000
-18% -$5.72M
PLTR icon
7
Palantir
PLTR
$448B
$23.3M 4.29%
200,000
ARWR icon
8
Arrowhead Research
ARWR
$12B
$19.1M 3.51%
234,222
-132,714
-36% -$9.8M
OPEN icon
9
Opendoor
OPEN
$3.19B
$18.2M 3.35%
+3,940,904
New +$18.9M
LMND icon
10
Lemonade
LMND
$4.1B
$17.6M 3.23%
270,259
+15,000
+6% +$877K
NVDA icon
11
NVIDIA
NVDA
$5.25T
$16.2M 2.98%
81,000
IREN icon
12
Iris Energy
IREN
$12.7B
$15.6M 2.86%
340,150
+20,000
+6% +$1.04M
QURE icon
13
uniQure
QURE
$3.38B
$15.1M 2.78%
328,322
-158,198
-33% -$4.14M
CBRS
14
Cerebras Systems
CBRS
$42.5B
$13.4M 2.46%
+60,500
New +$14.2M
ASTS icon
15
AST SpaceMobile
ASTS
$17.4B
$12.9M 2.37%
145,000
RARE icon
16
Ultragenyx Pharmaceutical
RARE
$2.52B
$11.3M 2.08%
338,800
-26,002
-7% -$646K
ARQT icon
17
Arcutis Biotherapeutics
ARQT
$2.99B
$10.5M 1.92%
399,367
+78,395
+24% +$1.83M
BIIB icon
18
Biogen
BIIB
$32.3B
$10.5M 1.92%
48,400
+4,600
+11% +$880K
PRQR icon
19
ProQR Therapeutics
PRQR
$323M
$10.3M 1.89%
5,520,024
+52,875
+1% +$87.1K
AXSM icon
20
Axsome Therapeutics
AXSM
$10.4B
$9.78M 1.8%
39,944
-18,785
-32% -$4.07M
URGN icon
21
UroGen Pharma
URGN
$2.13B
$7.73M 1.42%
210,000
-28,122
-12% -$762K
SPCX
22
SpaceX
SPCX
$1.86T
$6.83M 1.26%
+40,000
New +$6.8M
DNLI icon
23
Denali Therapeutics
DNLI
$3.84B
$5.91M 1.09%
229,857
-25,000
-10% -$514K
VRTX icon
24
Vertex Pharmaceuticals
VRTX
$137B
$4.67M 0.86%
9,400
-1,955
-17% -$866K
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12.5B
$4.29M 0.79%
75,000
-17,305
-19% -$948K

Similar funds

Privium Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, Privium Fund Management held 70 positions worth $544M, up 13% from $480M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Privium Fund Management's Q2 2026 filing shows 10 new, 18 increased, 20 reduced and 9 closed positions. Its largest new stake was Opendoor: 3,940,904 shares worth $18.2M. The largest sale was Coinbase, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Privium Fund Management's largest Q2 2026 buy was Opendoor: 3,940,904 shares worth $18.2M.
  • Privium Fund Management added most to Amazon in Q2 2026, an estimated $3.77M increase.
  • Privium Fund Management's biggest Q2 2026 reduction was Arrowhead Research, cutting an estimated $9.8M.
  • Privium Fund Management fully exited Coinbase in Q2 2026, selling an estimated $13.8M.
  • Privium Fund Management's ten largest holdings make up 62% of its $544M portfolio in Q2 2026.
  • Privium Fund Management opened 10 new positions and closed 9 in Q2 2026.
  • Privium Fund Management's portfolio value rose 13% quarter-over-quarter to $544M.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.